🔎 Trials Near Me

Dachaigh › Leukemia Myeloid Cronach › Texas › Houston

Sgrùdaidhean clionaigeach Leukemia Myeloid Cronach ann an Houston, TX

Tha 18 sgrùdaidhean airson Leukemia Myeloid Cronach a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • UT MD Anderson Cancer Center, Houston
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

A’ fastadhSgrùdadh amharc
  • Texas Children's Hospital, Houston
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

A’ fastadhÌre 2
  • The University of Texas M. D. Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07269470

Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

A’ fastadhÌre 2
  • MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06236724

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

A’ fastadhÌre 1
  • M D Anderson Cancer Center, Houston
Aoisean 1 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT03630991

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT01746836

Study of Olverembatinib (HQP1351) in Patients With CML-CP

A’ fastadhÌre 3
  • Ascentage Investigative Site #1501, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06423911

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital - Baylor Medical Center, Houston
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

Asciminib Roll-over Study

A’ fastadhÌre 4
  • Uni Of TX MD Anderson Cancer Cntr, Houston
Aoisean 7 gu 100 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT04877522

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT02115295

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

A’ fastadhSgrùdadh amharc
  • University of Texas MD Anderson Cancer Center, Houston
Gach aois · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT00816114

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

A’ fastadhÌre 1
  • The University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT05304377

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

A’ fastadhÌre 1
  • MD Anderson Cancer Center, Houston
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 16 Màrt 2026 · NCT06994676

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

A’ fastadhÌre 1/2
  • The University of Texas M.D. Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Faoi 2026 · NCT06163430

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

A’ fastadhÌre 1
  • University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Samh 2025 · NCT04260022

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

A’ fastadhÌre 1
  • The University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Gearr 2025 · NCT06088888

Sgrùdaidhean Leukemia Myeloid Cronach ann am bailtean eile

Sgrùdaidhean eile ann an Houston

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.